Transcription factor Blimp1 identified as potential target for modulating T-reg activity to treat cancer

By | December 22, 2021
In cancer, a major obstacle to anti-tumor immunity and immunotherapy treatment is the infiltration of regulatory T cells, or T-reg cells, into a tumor. These immune cells generally turn down the immune response, and they can prevent the immune system from destroying cancer cells.